Clinical Trials Logo

Clinical Trial Summary

To assess the impact of POKE on babies, the investigators will longitudinally track outcomes before and after implementation at Intermountain Healthcare's five NICUs. Process outcomes will include the number of total POKEs per baby and the number of painful POKEs per baby, each measured at both the patient-level and NICU-level. Clinical outcomes will include hospital acquired infections, length of stay, and mortality. Financial outcomes will include total variable costs and backfill rate. The effect of POKE on each of these outcomes will be measured using multivariable regression analysis with appropriate distributional families and interaction terms.


Clinical Trial Description

POKE was developed and implemented at Dixie Regional Medical Center's Neonatal Intensive Care Unit (NICU) over the past 10 years to eliminate waste and reduce harm in healthcare. POKE is a combination of a unique culture and process, with a supporting database, that is designed to guide and inform care decisions while minimizing POKEs. The program utilizes an implementation framework, educational materials, electronic health records (EHR), and decision support analytics. POKE's initial deployment showed extremely promising results for Intermountain, which included: (1) eliminating 11,000 POKEs per year (a 50% reduction in overall POKEs), (2) realizing $940,000 per year in cost savings (a 28% reduction of overall cost), (3) reducing length of stay by 2 weeks per average stay (a 21% reduction in length of stay), and (4) eliminating Hospital Acquired Infections (i.e., Central-line Associated Bloodstream Infection and Ventilator-associated Pneumonia), translating into 10 lives saved and a $5.2M savings over a decade. POKE will now be deployed and routinized within all Intermountain Healthcare NICUs and be developed as a commercial product for external customers. To assess the impact of POKE on babies, the investigators will longitudinally track several outcomes before and after implementation at Intermountain NICUs. Process outcomes will include the number of total POKEs per baby and the number of painful POKEs per baby, each measured at both the patient-level and NICU-level. Clinical outcomes will include hospital acquired infections, length of stay, and mortality. Financial outcomes will include total variable costs and backfill rate. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03688607
Study type Observational
Source Intermountain Health Care, Inc.
Contact R. Erick Ridout, MD
Phone 435-705-9208
Email Erick.Ridout@imail.org
Status Not yet recruiting
Phase
Start date October 1, 2018
Completion date May 31, 2019

See also
  Status Clinical Trial Phase
Withdrawn NCT03282292 - Central Venous Catheter Insertion Site and Colonization in Pediatric Cardiac Surgery N/A
Completed NCT05175027 - Preoperative Antiseptic in Newborn Circumcision Comparison of Povidone Iodine and Hypochlorous Acid Used N/A
Completed NCT04862403 - The Effect of Umbilical Cord Clamping Distance N/A
Completed NCT05226949 - Host RNA Expression Profiles and Protein Biomarkers in Neonatal Herpes Simplex Virus Infection
Completed NCT03183531 - New Protocol for Febrile Neonate Management N/A
Active, not recruiting NCT06389383 - Pilot Study - Monitoring the Nasal Microbiome and Viral Respiratory Infections in Newborn Hospitalized in Neonatalogy. N/A